文献速递其他结缔组织病

肌肉疾病中的营养干预与膳食补充剂:系统综述

Nutritional interventions and dietary supplements in muscle diseases: a systematic review.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该系统综述评估膳食干预及补充剂对肌肉疾病的安全性与疗效,共纳入51项研究。炎症性肌病中肌酸联合运动改善高强度功能表现,McArdle病中高碳水化合物饮食减轻运动相关症状,GNE肌病中aceneuramic酸呈剂量依赖性肌力改善。整体证据有限,尤其炎症性肌病。

要点

  • 炎症性肌病:肌酸联合运动6个月改善PM和DM高强度功能表现。
  • McArdle病:65%碳水化合物饮食减轻运动相关症状,高剂量肌酸反致症状恶化。
  • GNE肌病:aceneuramic酸6g/日48周呈剂量依赖性肌力改善并在日本获批。

核心结论

  • 肌肉疾病营养干预证据有限,尤其炎症性肌病。
  • 最强支持来自机制靶向方法:肌酸联合运动、McArdle病碳水化合物饮食、GNE肌病唾液酸。

研究设计与样本

  • 多学科团队按PRISMA指南开展、PROSPERO注册的系统综述。
  • 检索多个数据库,107篇全文筛选后51篇符合预设纳入标准。

主要发现

  • 多数干预为膳食补充剂而非整体饮食方案。
  • 炎症性肌病中肌酸(负荷20g/日、维持3g/日)联合运动6个月改善PM和DM高强度功能表现。
  • Duchenne肌营养不良中肌酸2-10g/日8-16周改善最大自主收缩和抗疲劳能力。
  • McArdle病中65%碳水化合物饮食减少运动相关症状,高剂量肌酸150mg/kg/日反而加重症状。
  • GNE肌病中aceneuramic酸6g/日48周呈剂量依赖性肌力改善并获日本监管批准。

关键数值与推荐

  • 质量评估:31%低偏倚风险,49%存在一些担忧,20%高偏倚风险。

临床怎么用

  • 炎症性肌病可考虑肌酸联合运动以改善高强度功能表现。
  • McArdle病可采用高碳水化合物饮食,避免高剂量肌酸。
  • GNE肌病可考虑aceneuramic酸治疗。

局限性

  • 证据整体有限,尤其炎症性肌病。
  • 多数研究为补充剂而非整体饮食干预。
  • 需足够样本量多中心试验及标准化结局,重点关注炎症性肌病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Medical nutrition therapy significantly impacts cardiovascular risk and overall health, but effects on muscle diseases remain unclear. This systematic review evaluates the safety and efficacy of dietary interventions and supplements on muscle disease outcomes. METHODS: A multidisciplinary team conducted a PRISMA-guided systematic review registered on PROSPERO. Searches were conducted across multiple databases and screened against pre-specified inclusion criteria. RESULTS: Of 107 full-text articles screened, 51 met inclusion criteria. Most identified interventions used dietary supplements rather than whole dietary approaches. In inflammatory myopathies, creatine (loading dose 20 g/day, maintenance 3 g/day) combined with exercise improved high-intensity functional performance in PM and DM over 6 months. In Duchenne muscular dystrophy, creatine (2-10 g/day for 8-16 weeks) improved maximal voluntary contraction and fatigue resistance. Carbohydrate-rich diets (65% CHO) reduced exercise-related symptoms in McArdle disease, while high-dose creatine (150 mg/kg/day) paradoxically worsened symptoms. Four trials of aceneuramic acid (6 g/day for 48 weeks) in GNE myopathy demonstrated dose-dependent strength improvements, leading to regulatory approval in Japan. High-protein supplementation showed positive trends for muscle preservation in critical illness myopathy. Quality assessment revealed 31% at low risk of bias, 49% with some concerns and 20% at high risk. CONCLUSION: Evidence for nutritional interventions in muscle diseases remains limited, especially for inflammatory myopathies. The strongest support emerged for mechanistically targeted approaches: creatine with exercise, carbohydrate-rich and ketogenic diets in McArdle disease and sialic acid in GNE myopathy. Future research requires adequately powered multicentre trials with standardized outcomes, with focus on inflammatory myopathies.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Talreja T, Vedantam D, Bandarupalli P, et al. Nutritional interventions and dietary supplements in muscle diseases: a systematic review. Rheumatology (Oxford). 2026. PMID: 42482152. doi:10.1093/rheumatology/keag378

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。